Loading organizations...
Loading organizations...
Innovative sustained-release drug delivery system using nanoparticles.
Zylö Therapeutics has raised $11.1M across 4 funding rounds.
Zylö Therapeutics has raised $11.1M in total across 4 funding rounds.
Zylö Therapeutics has raised $11.1M in total across 4 funding rounds.
Zylö Therapeutics's investors include James Cordes, Boston Harbor Angels, Cowtown Angels, Harvard Business School Alumni Angels of New York, New York Angels, SCRA Technology Ventures, VentureSouth, National Institute of Diabetes and Digestive and Kidney Diseases, Ariel Southeast Angel Partners, Chemical Angel Fund.
Zylö Therapeutics has raised $11.1M across 4 funding rounds. Most recently, it raised $5.2M Series B in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 3, 2022 | $5.2M Series B | James Cordes | Boston Harbor Angels, Cowtown Angels, Harvard Business School Alumni Angels of New York, New York Angels, SCRA Technology Ventures, VentureSouth |
| Jul 20, 2021 | $1.7M Grant | National Institute of Diabetes and Digestive and Kidney Diseases | |
| Nov 12, 2019 | $220K Grant | National Institute of Diabetes and Digestive and Kidney Diseases | |
| Sep 26, 2019 | $4.0M Series A | VentureSouth | Ariel Southeast Angel Partners, Boston Harbor Angels, Chemical Angel Fund, New York Angels, SCRA Technology Ventures |